Number of the records: 1  

HIF-1, Metabolism, and Diabetes in the Embryonic and Adult Heart

  1. 1.
    SYSNO ASEP0503021
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleHIF-1, Metabolism, and Diabetes in the Embryonic and Adult Heart
    Author(s) Čerychová, Radka (BTO-N)
    Pavlínková, Gabriela (BTO-N) RID, ORCID
    Number of authors2
    Article number460
    Source TitleFrontiers in Endocrinology. - : Frontiers Media - ISSN 1664-2392
    Roč. 9, AUG 15 2018 (2018)
    Number of pages14 s.
    Languageeng - English
    CountryCH - Switzerland
    Keywordshypoxia-inducible factor 1 ; embryopathy ; cardiomyopathy
    Subject RIVFB - Endocrinology, Diabetology, Metabolism, Nutrition
    OECD categoryEndocrinology and metabolism (including diabetes, hormones)
    R&D ProjectsGA16-06825S GA ČR - Czech Science Foundation (CSF)
    ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportBTO-N - RVO:86652036
    UT WOS000441562300001
    EID SCOPUS85052209773
    DOI10.3389/fendo.2018.00460
    AnnotationThe heart is able to metabolize any substrate, depending on its availability, to satisfy its energy requirements. Under normal physiological conditions, about 95% of ATP is produced by oxidative phosphorylation and the rest by glycolysis. Cardiac metabolism undergoes reprograming in response to a variety of physiological and pathophysiological conditions. Hypoxia-inducible factor 1 (HIF-1) mediates the metabolic adaptation to hypoxia and ischemia, including the transition from oxidative to glycolytic metabolism. During embryonic development, HIF-1 protects the embryo from intrauterine hypoxia, its deletion as well as its forced expression are embryonically lethal. A decrease in HIF-1 activity is crucial during perinatal remodeling when the heart switches from anaerobic to aerobic metabolism. In the adult heart, HIF-1 protects against hypoxia, although its deletion in cardiomyocytes affects heart function even under normoxic conditions. Diabetes impairs HIF-1 activation and thus, compromises HIF-1 mediated responses under oxygen-limited conditions. Compromised HIF-1 signaling may contribute to the teratogenicity of maternal diabetes and diabetic cardiomyopathy in adults. In this review, we discuss the function of HIF-1 in the heart throughout development into adulthood, as well as the deregulation of HIF-1 signaling in diabetes and its effects on the embryonic and adult heart.
    WorkplaceInstitute of Biotechnology
    ContactMonika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700
    Year of Publishing2019
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.